Georgia Theofan serves as Executive at IMMUNE RESPONSE CORP, where they oversee executive responsibilities. Since joining the company, Georgia Theofan has executed 10 insider transactions totaling $7.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 19, 2006 involved selling 720,000 shares valued at $1.4M.
Georgia Theofan currently holds 90,529 shares of IMMUNE RESPONSE CORP (IMNR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Georgia Theofan has been a net seller of IMNR stock. They have purchased $0 and sold $7.5M worth of shares.
Georgia Theofan's most recent insider trade was on Oct 19, 2006, when they sold 720,000 shares at $2.00 per share.
Get notified when new Form 4 filings are submitted
| $0.02 |
| Discretionary |
| Sep 15, 2006 | OCHT | $300.0K | Sale | 150,000 | $2.00 | Discretionary |
| Sep 8, 2006 | OCHT | $4.4M | Sale | 2,180,000 | $2.00 | Discretionary |
| Aug 31, 2006 | OCHT | $400.0K | Sale | 200,000 | $2.00 | Discretionary |
| Aug 29, 2006 | OCHT | $500.0K | Sale | 250,000 | $2.00 | Discretionary |
| Aug 25, 2006 | OCHT | $500.0K | Sale | 250,000 | $2.00 | Discretionary |
| Jun 30, 2006 | IMNR | $503 | Award | 25,155 | $0.02 | Discretionary |
| Mar 31, 2006 | IMNR | $503 | Award | 4,574 | $0.11 | Discretionary |
| Dec 30, 2005 | IMNR | $481 | Award | 6,016 | $0.08 | Discretionary |